Stock MIST MILESTONE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Milestone Pharmaceuticals Inc.

Equities

MIST

CA59935V1076

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
1.38 USD -0.72% Intraday chart for Milestone Pharmaceuticals Inc. -2.13% -17.37%
06-20 Transcript : Milestone Pharmaceuticals Inc. - Special Call
05-29 Milestone Pharmaceuticals Says US FDA Accepts New Drug Application for Cardamyst Nasal Spray for Arrhythmia MT

Business Summary

Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.

Number of employees: 47

Sales per Business

USD in Million2022Weight2023Weight Delta
Cardiovascular Medicines
100.0 %
5 100.0 % 1 100.0 % -80.00%

Sales per region

USD in Million2022Weight2023Weight Delta
Canada
100.0 %
5 100.0 % 1 100.0 % -80.00%

Managers

Managers TitleAgeSince
Joseph Oliveto CEO
 Chief Executive Officer 56 17-03-06
Amit Hasija DFI
 Director of Finance/CFO 51 19-09-08
Anita Holz CTO
 Chief Tech/Sci/R&D Officer - 22-07-31
Debbie K. Everidge CTO
 Chief Tech/Sci/R&D Officer - 21-10-31
David Bharucha CTO
 Chief Tech/Sci/R&D Officer 62 22-02-14
Jeff Nelson COO
 Chief Operating Officer 42 20-05-31
Kimberly Sheehan HRO
 Human Resources Officer - 22-03-31
Roshan Girglani SAM
 Sales & Marketing - 22-07-31
Lorenz Muller PRN
 Corporate Officer/Principal 60 17-09-30
Guy Rousseau LAW
 General Counsel - 15-12-31

Members of the board

Members of the board TitleAgeSince
Seth Fischer BRD
 Director/Board Member 68 23-03-20
Joseph Oliveto CEO
 Chief Executive Officer 56 17-03-06
Debra Liebert BRD
 Director/Board Member 67 15-05-31
Richard Pasternak BRD
 Director/Board Member 75 19-11-10
Michael Tomsicek BRD
 Director/Board Member 58 19-03-31
Lisa Giles BRD
 Director/Board Member 65 20-09-30
Robert Wills CHM
 Chairman 70 20-09-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 53,260,467 52,890,840 ( 99.31 %) 0 99.31 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
9.334 %
4,971,344 9.334 % 7 M $
RTW Investments LP
6.114 %
3,256,102 6.114 % 5 M $
Millennium Management LLC
5.362 %
2,855,612 5.362 % 4 M $
Alta Fundamental Advisers LLC
4.452 %
2,371,289 4.452 % 4 M $
Lion Point Capital LP
4.319 %
2,300,207 4.319 % 3 M $
Citadel Securities GP LLC
4.267 %
2,272,404 4.267 % 3 M $
OrbiMed Advisors Private Equity
3.755 %
2,000,000 3.755 % 3 M $
Nantahala Capital Management LLC
3.286 %
1,750,000 3.286 % 3 M $
Stonepine Capital Management LLC
2.746 %
1,462,296 2.746 % 2 M $
Goldman Sachs & Co. LLC
2.540 %
1,353,067 2.540 % 2 M $

Company contact information

Milestone Pharmaceuticals, Inc.

1111 Dr. Frederik-Philips Boulevard Suite 420

H4M 2X6, Montréal

+

http://www.milestonepharma.com
address Milestone Pharmaceuticals Inc.(MIST)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.38 USD
Average target price
10.25 USD
Spread / Average Target
+642.75%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
MILESTONE PHARMACEUTICALS INC. Stock Milestone Pharmaceuticals Inc.
-17.37% 91.29M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+15.19% 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+19.91% 114B
ARGENX SE Stock argenx SE
+8.24% 23.61B
BIONTECH SE Stock BioNTech SE
-19.80% 20.43B
GENMAB A/S Stock Genmab A/S
-16.19% 16.55B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.45% 16.45B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-44.35% 15.59B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+66.67% 15.19B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.13% 13.54B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. MIST Stock
  4. Company Milestone Pharmaceuticals Inc.